Vaccines

ImmunoCellular Therapeutics to Present at the 13th Annual Rodman & Renshaw Global Investment Conference on September 13th

Published in Drug Law Weekly, September 20th, 2011

2011 SEP 20 -- ImmunoCellular Therapeutics, Ltd. (OTC.BB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced that the company will present at the Rodman & Renshaw 13th Annual Global Investment Conference at the Waldorf Astoria in New York City on September 13th. The presentation will be given at 9:10 a.m. Eastern Daylight Time in Starlight South room.

The Company's presentation will be webcast at: http://wsw.com/webcast/rrshq20/imuc.ob About ImmunoCellular Therapeutics, Ltd. IMUC is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2011-09-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry